IL156138A0 - Excitatory amino acid receptor antagonists - Google Patents
Excitatory amino acid receptor antagonistsInfo
- Publication number
- IL156138A0 IL156138A0 IL15613801A IL15613801A IL156138A0 IL 156138 A0 IL156138 A0 IL 156138A0 IL 15613801 A IL15613801 A IL 15613801A IL 15613801 A IL15613801 A IL 15613801A IL 156138 A0 IL156138 A0 IL 156138A0
- Authority
- IL
- Israel
- Prior art keywords
- amino acid
- receptor antagonists
- acid receptor
- excitatory amino
- excitatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 | |
| PCT/US2001/044715 WO2002053561A1 (en) | 2001-01-05 | 2001-12-20 | Excitatory amino acid receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL156138A0 true IL156138A0 (en) | 2003-12-23 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15613801A IL156138A0 (en) | 2001-01-05 | 2001-12-20 | Excitatory amino acid receptor antagonists |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (zh) |
| JP (1) | JP2004520335A (zh) |
| KR (1) | KR20030066797A (zh) |
| CN (1) | CN1484642A (zh) |
| AR (1) | AR035679A1 (zh) |
| BR (1) | BR0116672A (zh) |
| CA (1) | CA2431545A1 (zh) |
| CZ (1) | CZ20031856A3 (zh) |
| DZ (1) | DZ3460A1 (zh) |
| EA (1) | EA200300770A1 (zh) |
| EC (1) | ECSP034682A (zh) |
| HR (1) | HRP20030544A2 (zh) |
| HU (1) | HUP0302528A2 (zh) |
| IL (1) | IL156138A0 (zh) |
| MX (1) | MXPA03005981A (zh) |
| NO (1) | NO20032973L (zh) |
| NZ (1) | NZ525821A (zh) |
| PE (1) | PE20020792A1 (zh) |
| PL (1) | PL361934A1 (zh) |
| SK (1) | SK8242003A3 (zh) |
| TW (1) | TW591023B (zh) |
| WO (1) | WO2002053561A1 (zh) |
| ZA (1) | ZA200304311B (zh) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| IL137684A0 (en) * | 1998-02-06 | 2001-10-31 | Smithkline Beechmam Plc | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| DK1200073T3 (da) * | 1999-07-06 | 2007-05-07 | Lilly Co Eli | Selektive iGluR5-receptorantagonister til behandling af migræne |
-
2001
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Application Discontinuation
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Application Discontinuation
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
-
2002
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973L/no not_active Application Discontinuation
- 2003-07-03 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK8242003A3 (en) | 2004-01-08 |
| PE20020792A1 (es) | 2002-09-06 |
| CN1484642A (zh) | 2004-03-24 |
| TW591023B (en) | 2004-06-11 |
| ZA200304311B (en) | 2004-09-02 |
| JP2004520335A (ja) | 2004-07-08 |
| ECSP034682A (es) | 2003-08-29 |
| NO20032973D0 (no) | 2003-06-27 |
| NO20032973L (no) | 2003-06-27 |
| NZ525821A (en) | 2004-07-30 |
| KR20030066797A (ko) | 2003-08-09 |
| AR035679A1 (es) | 2004-06-23 |
| PL361934A1 (en) | 2004-10-18 |
| HRP20030544A2 (en) | 2004-08-31 |
| BR0116672A (pt) | 2003-09-23 |
| MXPA03005981A (es) | 2003-09-10 |
| HUP0302528A2 (hu) | 2003-11-28 |
| DZ3460A1 (fr) | 2002-07-11 |
| CA2431545A1 (en) | 2002-07-11 |
| EA200300770A1 (ru) | 2003-10-30 |
| CZ20031856A3 (cs) | 2003-09-17 |
| WO2002053561A1 (en) | 2002-07-11 |
| EP1351955A1 (en) | 2003-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT1539766T (lt) | Su kalcitonino genu susijusio peptido receptoriaus antagonistai | |
| IL165841A0 (en) | Mchir antagonists | |
| IL157705A0 (en) | Igf antagonist peptides | |
| HUP0303730A2 (en) | Disease-associated protein | |
| HK1066787A1 (en) | Nk1 antagonists nk1 | |
| HK1063791A1 (en) | Nk1 antagonists | |
| EP1359915A4 (en) | UROTENSIN-II RECEPTOR ANTAGONISTS | |
| EP1372688A4 (en) | SOMATOSTATIN ANTAGONISTS | |
| EP1409517A4 (en) | FUSION PROTEIN WITH SOMATOSTATIN RECEPTORS | |
| AU2002359524A8 (en) | P2x7 receptor antagonists | |
| PT1368032E (pt) | Antagonistas de receptores dos aminoácidos excitadores | |
| PL370367A1 (en) | Ccr-3 receptor antagonists v | |
| IL156138A0 (en) | Excitatory amino acid receptor antagonists | |
| GB0101223D0 (en) | Histamine receptor antagonists | |
| AU2002227020A1 (en) | Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists | |
| AU2002228736A1 (en) | Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists | |
| AU6455501A (en) | Excitatory amino acid receptor modulators | |
| GB0306428D0 (en) | Receptor proteins | |
| AU2003219955A1 (en) | Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists | |
| GB0128161D0 (en) | Receptor protein | |
| AU2001264554A1 (en) | Excitatory amino acid receptor modulators | |
| SI1379239T1 (sl) | N-(2-ariletil)benzilamini, uporabljeni kot antagonisti receptorja 5-ht6 | |
| AU2003212418A8 (en) | Peptide deformylase | |
| GB0220459D0 (en) | Receptor proteins | |
| GB0223877D0 (en) | Receptor proteins |